CHINA PHARMA HOLDINGS, INC.

Regulatory Filings • Nov 3, 2017

DEFA14A 1 defa14a110317_chinapharma.htm DEFINITIVE ADDITIONAL MATERIALS

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant þ

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☐ | Preliminary
Proxy Statement |
| --- | --- |
| ☐ | Confidential,
for Use of the Commission Only (as permitted by Rule 14a- 6(e)(2) ) |
| ☐ | Definitive
Proxy Statement |
| þ | Definitive
Additional Materials |
| ☐ | Soliciting
Material Pursuant to §240.14a-12 |

CHINA PHARMA HOLDINGS, INC.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

| þ | No
fee required. |
| --- | --- |
| ☐ | Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |

| (1) | Title
of each class of securities to which transaction applies: |
| --- | --- |
| (2) | Aggregate
number of securities to which transaction applies: |
| (3) | Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined): |
| (4) | Proposed
maximum aggregate value of transaction: |
| (5) | Total
fee paid: |

| ☐ | Fee
paid previously with preliminary materials. |
| --- | --- |
| ☐ | Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
of its filing. |

| (1) | Amount
Previously Paid: |
| --- | --- |
| (2) | Form,
Schedule or Registration Statement No.: |
| (3) | Filing
Party: |
| (4) | Date
Filed: |

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

| CHINA
PHARMA HOLDINGS, INC. | | | |
| --- | --- | --- | --- |
| | | REQUEST
ID: | |
| IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS for the Annual Meeting of Stockholders | | | |
| | DATE: | December
14, 2017 | |
| | TIME: | 8:00
p.m. Eastern Time (December 15, 2017 at 9:00 a.m. local time) | |
| | LOCATION: | Conference
Room, 2nd Floor, of the Jiahai Building, No. 17 Jinpan Road, Haikou, Hainan Province, China 570216 | |
| HOW
TO REQUEST PAPER COPIES OF OUR MATERIALS | | | |
| ● | ● | ● | ● |
| PHONE: Call
toll free 1-866-752-8683 | FAX: Send
this card to 202-521-3464 | INTERNET: https://www.iproxydirect.com/CPHI and follow the on-screen instructions. | EMAIL: proxy@iproxydirect.com Include your Control ID in your email. |
| This
communication represents a notice to access a more complete set of proxy materials available to you on the Internet. We encourage
you to access and review all of the important information contained in the proxy materials before voting. The proxy statement
is available at: https://www.iproxydirect.com/CPHI | | | |
| If
you want to receive a paper copy of the proxy materials you must request one. There is no charge to you for requesting a copy.
To facilitate timely delivery please make the request, as instructed above, before December 1, 2017. | | | |
| you
may enter your voting instructions at https://www.iproxydirect.com /CPHI until 11:59 pm eastern
time December 13, 2017 | | | |
| The
purposes of this meeting are as follows: | | | |
| 1. To elect three independent director nominees to our Board of Directors to serve until the next annual meeting and until their successors are elected and qualified; and 2. To transact such other business as may properly come before the annual meeting or any adjournment thereof. | | | |
| Pursuant
to Securities and Exchange Commission rules, you are receiving this Notice that the proxy materials for the Annual meeting
are available on the Internet. Follow the instructions above to view the materials and vote or request printed copies. The
board of directors has fixed the close of business on November 31, 2017 as the record date for the determination of stockholders
entitled to receive notice of the Annual Meeting and to vote the shares of our common stock and Series A Convertible Preferred
Stock. | | | |
| THE
BOARD, INCLUDING THE INDEPENDENT DIRECTORS, UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR
ALL” EACH OF THE NOMINEES IN PROPOSAL ONE. | | | |
| Please
note - This is not a Proxy Card - you cannot vote by returning this card | | | |

Field: Page; Sequence: 1

Field: /Page

CHINA PHARMA HOLDINGS, INC. SHAREHOLDER SERVICES 500 Perimeter Park Drive Suite D Morrisville NC 27560 FIRST-CLASS MAIL US POSTAGE PAID RALEIGH NC PERMIT # 870

Time Sensitive shareholder information enclosed

IMPORTANT SHAREHOLDER INFORMATION

your vote is important

Field: Page; Sequence: 2

Field: /Page

| CHINA
PHARMA HOLDINGS, INC. THIS
PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS annual
meeting OF STOCKHOLDERS – december 14, 2017 at 8:00 p.m. Eastern Time (December 15, 2017 at 9:00 a.m. local time) | | |
| --- | --- | --- |
| CONTROL
ID: | | |
| REQUEST
ID: | | |
| This
Proxy is Solicited on Behalf of the Board of Directors of China Pharma Holdings, Inc. The undersigned hereby appoints
Zhilin Li as proxy, with full power of substitution, to vote as designated below all of the shares the undersigned is entitled
to vote at the Annual Meeting of Stockholders to be held at the Conference Room, 2 nd Floor, of the Jiahai Building,
No. 17 Jinpan Road, Haikou, Hainan Province, China 570216 on December 14, 2017, at 8:00 p.m., Eastern Time (Friday, December
15, 2017 at 9:00 a.m. local time), and any adjournments or postponements thereof, and otherwise to represent the undersigned
at the meeting, with all powers possessed by the undersigned if personally present at the meeting. | | |
| (CONTINUED
AND TO BE SIGNED ON REVERSE SIDE.) | | |
| VOTING
INSTRUCTIONS | | |
| If you
vote by phone, fax or internet, please DO NOT mail your proxy card. | | |
| ● | MAIL: | Please mark, sign, date, and
return this Proxy Card promptly using the enclosed envelope. |
| ● | FAX: | Complete the reverse portion
of this Proxy Card and Fax to 202-521-3464. |
| ● | INTERNET: | https://www.iproxydirect.com/CPHI |
| ● | PHONE: | 1-866-752-VOTE(8683) |

Field: Page; Sequence: 2

Field: /Page

| ANNUAL
MEETING OF THE STOCKHOLDERS OF CHINA PHARMA HOLDINGS, INC. | | PLEASE
COMPLETE, DATE, SIGN AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE: ý | | | |
| --- | --- | --- | --- | --- | --- |
| PROXY
SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS | | | | | |
| Proposal 1 | à | FOR ALL | AGAINST ALL | FOR
ALL EXCEPT | |
| To elect
three independent director nominees to our Board of Directors to serve until the next annual meeting and until their successors
are elected and qualified | | ¨ | ¨ | | |
| Gene
Michael Bennett | | | | ¨ | |
| Yingwen Zhang | | | | ¨ | Control ID: |
| Baowen Dong | | | | ¨ | REQUEST ID: |
| Proposal 2 | | | | | |
| To transact such other business as may
properly come before the Annual Meeting or any adjournment thereof. | | | | | |
| | | | MARK “X”
HERE IF YOU PLAN TO ATTEND THE MEETING: ¨ | | |
| Our
Board of Directors recommends a vote “FOR ALL” election of each of the nominees listed in Proposal
1. | | | MARK HERE
FOR ADDRESS CHANGE ¨ New Address (if applicable): ____ ____ ____ IMPORTANT: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign.
When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer
is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is
a partnership, please sign in partnership name by authorized person. Dated: ______,
2017 | | |
| | | | (Print
Name of Stockholder and/or Joint Tenant) | | |
| | | | (Signature
of Stockholder) | | |
| | | | (Second Signature if held jointly) | | |

Field: Rule-Page

Field: /Rule-Page